![Jeffrey Molldrem](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeffrey Molldrem
Keine laufenden Positionen mehr
Profil
Jeffrey Molldrem was the founder of The Vaccine Co. where he held the title of Director.
The company was founded in 2003.
He earned a doctorate degree from the University of Minnesota in 1990.
Ehemalige bekannte Positionen von Jeffrey Molldrem
Unternehmen | Position | Ende |
---|---|---|
The Vaccine Co.
![]() The Vaccine Co. BiotechnologyHealth Technology The Vaccine Co. develops therapeutic vaccines for the treatment of leukemias and other types of cancers. Its products include Proteinase 3 PR1 peptide vaccine, Proteinase 3 PR1 peptide vaccine, and Myelodysplastic Syndrome. The company was founded by Jeffrey Molldrem, Ronald B. Garren, Gregory C. Thayer, and Craig S. Rosenfeld in 2003 and is headquartered in San Francisco, CA. | Gründer | - |
Ausbildung von Jeffrey Molldrem
University of Minnesota | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
The Vaccine Co.
![]() The Vaccine Co. BiotechnologyHealth Technology The Vaccine Co. develops therapeutic vaccines for the treatment of leukemias and other types of cancers. Its products include Proteinase 3 PR1 peptide vaccine, Proteinase 3 PR1 peptide vaccine, and Myelodysplastic Syndrome. The company was founded by Jeffrey Molldrem, Ronald B. Garren, Gregory C. Thayer, and Craig S. Rosenfeld in 2003 and is headquartered in San Francisco, CA. | Health Technology |